Investor List:

Top Drug Delivery Series B Investors in San Francisco Bay Area (7)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Andrew Lee, Senior Associate at Northpond Ventures
Andrew Lee
Northpond Ventures·Senior Associate
Sweet spot: $10
Range: $1 - $40
Investors in Washington (D.C.), Investors in San Francisco (CA)
Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Seed), Investors in Chemicals (Series B), Investors in BioTech (Seed), Investors in Diverse Investors (Other Lists), Investors in AgTech (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Chemicals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in AgTech (Series B), Investors in BioTech (Series B), Investors in Chemicals (Series B), Investors in Washington, D.C. (Other Lists), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Series B), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
Photo of Steven Berger, Managing Director at Asahi Kasei Corporate Venture Capital
Steven Berger
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts, Investors in Berkeley (CA)
Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in Impact (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Food and Beverage (Seed), Investors in AgTech (Seed), Investors in EnergyTech (Series B), Investors in Food and Beverage (Series B), Investors in EnergyTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Impact (Series B), Investors in IoT (Seed), Investors in Food and Beverage (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in IoT (Series B), Investors in Impact (Series A), Investors in IoT (Series A), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in Food and Beverage (Seed), Investors in Impact (Seed), Investors in IoT (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in AgTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Impact (Series A), Investors in EnergyTech (Series A), Investors in Food and Beverage (Series A), Investors in IoT (Series A), Investors in EnergyTech (Series B), Investors in AgTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in IoT (Series B), Investors in Food and Beverage (Series B), Investors in Impact (Series B), Investors in AutoTech (Series B), Investors in AutoTech (Seed), Investors in AutoTech (Series A), Investors in ConstructionTech (Seed), Investors in ConstructionTech (Series B), Investors in ConstructionTech (Series A), Investors in AutoTech (Seed), Investors in AutoTech (Series B), Investors in Drug Delivery (Series A), Investors in ConstructionTech (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in AutoTech (Series A), Investors in Drug Delivery (Series B), Investors in ConstructionTech (Series B), Investors in Drug Delivery (Series B), Investors in ConstructionTech (Seed), Investors in Drug Delivery (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Impact (Pre-seed), Investors in AgTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in ConstructionTech (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in IoT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Impact (Pre-seed), Investors in IoT (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in ConstructionTech (Pre-seed), Investors in AutoTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Amad Elia, Venture Partner at Ganas Ventures
Amad Elia
Ganas Ventures·Venture Partner
Sweet spot: $50K
Range: $50K - $100K
Investors in Chicago (IL), Investors in Ann Arbor (MI), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in Midwest (Other Lists), Investors in Boston / New England (Other Lists), Investors in AR/VR (Series B), Investors in AR/VR (Series A), Investors in AR/VR (Seed), Investors in BioTech (Series B), Investors in E-commerce (Series B), Investors in BioTech (Series A), Investors in E-commerce (Series B), Investors in Gaming/eSports (Seed), Investors in AI (Seed), Investors in E-commerce (Seed), Investors in AR/VR (Series B), Investors in Gaming/eSports (Series B), Investors in Gaming/eSports (Series B), Investors in Gaming/eSports (Seed), Investors in Health & Hospital Services (Seed), Investors in Gaming/eSports (Series A), Investors in BioTech (Seed), Investors in AI (Seed), Investors in E-commerce (Seed), Investors in AR/VR (Series A), Investors in Gaming/eSports (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in AI (Series B), Investors in BioTech (Seed), Investors in E-commerce (Series A), Investors in BioTech (Seed), Investors in Gaming/eSports (Seed), Investors in BioTech (Series A), Investors in E-commerce (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in AI (Seed), Investors in AR/VR (Seed), Investors in Health & Hospital Services (Series B), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in E-commerce (Series B), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in AR/VR (Seed), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in AR/VR (Seed), Investors in E-commerce (Series A), Investors in Health & Hospital Services (Seed), Investors in E-commerce (Seed), Investors in E-commerce (Series A), Investors in Gaming/eSports (Series A), Investors in BioTech (Series A), Investors in Gaming/eSports (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in AR/VR (Series A), Investors in AR/VR (Series A), Investors in E-commerce (Series A), Investors in AI (Series A), Investors in Gaming/eSports (Series A), Investors in Gaming/eSports (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in AR/VR (Series B), Investors in AR/VR (Series B), Investors in E-commerce (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Gaming/eSports (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Drug Delivery (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Digital Health (Seed), Investors in Drug Delivery (Series B), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Digital Health (Seed), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Drug Delivery (Series B), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in AR/VR (Pre-seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Generative Tech/AI (Pre-seed), Investors in Direct-to-Consumer (DTC) (Series B), Investors in Digital Health (Series B), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Direct-to-Consumer (DTC) (Seed), Investors in AI (Pre-seed), Investors in AR/VR (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in E-commerce (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AR/VR (Pre-seed), Investors in BioTech (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in BioTech (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in AI (Pre-seed), Investors in Generative Tech/AI (Series B), Investors in AI (Pre-seed), Investors in E-commerce (Pre-seed), Investors in BioTech (Pre-seed), Investors in E-commerce (Pre-seed), Investors in E-commerce (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in Gaming/eSports (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Direct-to-Consumer (DTC) (Pre-seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Drug Delivery (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in AI (Seed), Investors in Investors who invested in female founders (Other Lists)
Photo of Mike Kramer, Venture Partner at Vensana Capital
Mike Kramer
Vensana Capital·Venture Partner
Sweet spot: $25.0M
Range: $10.0M - $40.0M
Investors in Santa Rosa (CA)
Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Medical Devices (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Alex Efron, Associate at Telegraph Hill Partners
Alex Efron
Sweet spot: $15.0M
Range: $7.0M - $50.0M
Investors in San Francisco (CA)
Photo of Eric Anschutz
Eric Anschutz
Sweet spot: $25K
Range: $10K - $250K
Investors in Boston (MA), Investors in San Francisco (CA), Investors in Shanghai, Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in San Jose (CA), Investors in Oakland (CA), Investors in Emeryville (CA), Investors in Seattle (WA), Investors in British Columbia
Investors in Material Science (Seed), Investors in AI (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Material Science (Series A), Investors in Seattle / Portland (Other Lists), Investors in Space (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Seed), Investors in AI (Seed), Investors in Space (Series A), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Space (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in Space (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Space (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Space (Series A), Investors in AI (Series B), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in British Columbia (Other Lists), Investors in Space (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in DeepTech (Series B), Investors in Space (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Therapeutics (Series A), Investors in Space (Pre-seed), Investors in Space (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in BioTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in AI (Seed)
Photo of Marguerite Davis, Foresite Capital
Marguerite Davis
Sweet spot: $38.5M
Range: $2.0M - $75.0M
Investors in SF Bay Area (CA)
Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Seed), Investors in Therapeutics (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Drug Delivery (Seed), Investors in Digital Health (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists)
Get new data & insights delivered to your inbox